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Ru(II)-polypyridyl surface functionalised gold nano-
particles as DNA targeting supramolecular structures 
and luminescent cellular imaging agents  
Miguel Martínez-Calvo,‡a Kim N. Orange,‡b Robert B. P. Elmes,a,c Bjørn la 
Cour Poulsen,a D. Clive Williams*b and Thorfinnur Gunnlaugsson*a 
The development of 15 nm (average size) Ru(II) functionalized gold nanoparticles 1-3.AuNP is 
described. These systems were found to be mono-disperse with a hydrodynamic radius of ca. 15 
nm in water but gave rise to the formation of higher order structures in buffered solution. The 
interaction of 1-3.AuNP with DNA was also studied by spectroscopic and microscopic methods 
and suggested the formation of large self-assembly structures in solution. The uptake of 1-
3.AuNP by cancer cells was studied using both confocal fluorescence as well as transmission 
electron microscopy (TEM), with the aim of investigating their potential as tools for cellular 
biology. These systems displaying a non-toxic profile with favourable photophysical properties 
may have application across various biological fields including diagnostics and therapeutics. 
Introduction	  
Nanoparticles (NPs) are defined as solid materials with a 
nanometric particle size. Metallic nanoparticles, due to their 
tuneable size, shape and biocompatibility, have been shown to 
be effective materials for use in biomedical applications, as a 
vast variety of chemical species can be anchored to their 
surface.1 Nanoparticles offer great potential for diagnostic and 
therapeutic applications over that of single molecules,2 where 
intrinsic features such as optical, magnetic, thermal or 
mechanical properties permit vast potential applications. To 
date NPs have been capitalised on for use in applications such 
as in molecular recognition, cellular signalling, drug delivery 
and sensing/bio-sensing to name just a few key areas.3 Most 
recently, the use of NPs to deliver cargo into cells has shown 
particular promise and has been extensively demonstrated by 
the work of Mirkin et al.1a,1d,2k,2l,3a,3d,3k,3o and Rotello, et 
al.1a,1f,2b,2h,3p,3r The small size of NPs and their large surface area 
allows anchoring of a large variety of ligands. Gold 
nanoparticles (AuNPs), in particular are highly attractive 
inorganic NPs that offer robust frameworks in which several 
components can be incorporated to give multifunctional 
capabilities.2,3 AuNPs are stable structures that can be easily 
synthesized and functionalized under ambient conditions.1 
AuNPs are thought to be relatively non-cytotoxic as the bulk 
form of the metal is chemically inert, and any toxicity is usually 
associated with their surface modified groups/ligands rather 
than gold itself.2,3 Mirkin et al., have pioneered the use of 
AuNPs as drug carriers, photo-responsive therapeutics, imaging 
agents and gene regulating agents.3a Hence, these are clearly 
highly attractive platforms with great potential for medical 
applications. 
   Ruthenium (Ru(II)) based polypyridyl complexes have also 
been intensively studied to date due to their rich photophysical 
properties, and they have found application in various fields of 
research. In particular, Ru(II) based polypyridyl complexes 
have been developed as sensitive and structure specific 
luminescent DNA probes and photoreagents.4 Here, the binding 
to DNA can occur either through intercalation5 or by groove 
binding6 causing modulation in the photophysical properties of 
the Ru-complexes; being dictated by the structural and physical 
nature of the polypyridyl ligands employed. Since targeting 
DNA with such complexes can prevent DNA replication within 
cancer cells and induce programmed cell death,7,8,9 it is of 
interest to develop new means of delivery into cells. Recently 
several examples of Ru(II) polypyridyl complexes have 
exhibited  live cellular uptake with many being localized in 
both nuclei, mitochondria, lysosomes and endoplasmic 
reticulum.10 However, to date, examples of Ru(II) 
functionalised NPs, which provide possibility of delivering high 
concentrations of Ru(II) complexes into live cells, remain 
few.11 Pikramenou and co workers have recently studied the 
luminescent properties of several Ru(II) functionalised NPs,11j,k 
coated with a fluorinated surfactant, and shown that the 
emission properties (including lifetimes and quantum yields) of 
such conjugated systems is (AuNP) distance depended and can 
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be enhanced over the individual complexes, which is highly 
desirable for application in biology. We have recently 
developed cell targeted probes capable of penetrating cells and 
inducing apoptosis using both organic, as well as metal ion 
complexes.12,13 In addition to these studies our group was the 
first to demonstrate the use of luminescent Ru(II)-polypyridyl 
conjugated to AuNP (Ru(II)-AuNPs). While we demonstrated 
that the photophysical properties of the Ru(II) complexes were 
preserved, the small size of AuNPs used, (average size of 4-5 
nm), limited their applications, where it proved difficult to 
further investigate and characterize their uptake mechanism in 
cancer cells.11a As the size of the AuNP is know to be able to 
strongly influence the chemistry and the physical properties of 
the surfaced functionalised ligands themselves (e.g. due to 
backing, self-assembly interactions, etc.), as well as the their 
biological properties (interactions with membrane bound 
proteins, etc.), we set out to investigate the use of larger AuNPs 
for cellular applications, in the hope of profiling the mechanism 
of cellular uptake in more detail and their subsequent 
distribution in the cytosol of such Ru(II)-AuNPs conjugates. 
We foresaw that our investigations would contribute to the 
general understanding of the behaviour of such nano-structures 
in biological environment to their possible application in 
biological media; particular in imaging and for the delivery of 
novel targeting therapeutics. To enable a direct comparison 
with our previous work, we have synthesized the polypyridyl 
complexes 1, 2 and 3, which have been tethered, via a phen 
spacer, to AuNPs with a larger diameter of ca. 30-40 nm 
(1.AuNP, 2.AuNP and 3.AuNP, Figure 1). Herein, we present 
our results, where we undertaken a detailed investigation of the 
physical and photophysical properties of these new 
nanostructures, their ability to interact with DNA and their 
biological activities in a cervical cancer cell line, using confocal 
fluorescence and transmission electron microscopy’, which 
demonstrates that while the increasing size of the AuNP allows 
for cellular uptakes studies to be profiled more accurately, the 
enhanced populate of the complexes at the AuNP surface 
greatly affects their application due to increased inter- and 
intramolecular interactions.  
 
Figure	  1.	  The Ru(II)polypyridyl complexes-AuNP hybrid materials 1-3.AuNP on 
15 nm gold nanoparticles developed for this study. These were formed by surface 
modification of freshly made AuNP using the thiol-terminal conjugated 
complexes 1-3 (See ESI for detail).	  
Results	  and	  Discussion	  
Synthesis and characterisation of 1-3.AuNP 
The synthesis of 1-3 was achieved according to Scheme S1 (see 
ESI). This involved the formation of the Ru(II) precursors cis-
[Ru(bpy)2Cl2], cis-[Ru(TAP)2Cl2], [RuCl2(η4-COD)] in 
accordance with established literature procedures, which were 
then reacted with phen derivative 4 (See ESI, Scheme 1) 11-
mercapto-N-(1,10-phenanthrolin-5-yl)-undecanamide in a 
single step using a peptide coupling reaction.11a All the 
complexes were analysed using conventional methods (See 
ESI), the absorption spectra of each in water and buffered pH 
7.4 solution are included in the ESI. The AuNP employed, in 
the formation of 1-3.AuNP, were formed using the established 
sodium citrate method, which resulted in the formation of ca. 
15-20 nm AuNP according to TEM analysis.14  
   The formation of 1-3.AuNP was achieved by carrying out 
surface modification of the AuNPs in water (See 
Experimental). In the case of 1-3.AuNP, this involved the 
addition of the appropriate Ru complex (in water) to an aqueous 
solution of AuNPs. Adjustment of the pH of the reaction to pH 
3, using HCl, followed by stirring at room temperature for 12 
hours provided the desired Ru(II) functionalized AuNPs 1-
3.AuNP. Purification was achieved by addition of a 
concentrated solution of ammonium hexafluorophosphate to an 
aqueous solution of 1-3.AuNP, followed by centrifugation, 
where the isolated solid was washed with MeOH. A second 
anion exchange process was achieved by firstly dissolving the 
isolated solid in CH3CN, before addition of a concentrated 
solution of tetrabutylammonium chloride. The resulting 
suspension was then centrifuged, and the isolated dark solid 
was washed with acetone. The full upload over the surface of 
the AuNP will compromise ca. 3000-4000 of the Ru(II) 
complexes 1-3.13e The resulting surface modified AuNPs were 
analysed using UV-Vis absorption spectroscopy, Dynamic 
Light Scattering (DLS) and Transmission Electron Microscopy 
(TEM) imaging in both water and in buffered solution at pH 
7.4. Recording the Zeta potential, gave rise to a positive 
potential of 19 mV in the case of 3.AuNP, indicating the 
cationic nature of the AuNP after surface modification with 3. 
In the cases of 1-2.AuNP the value obtained for the Zeta 
potential was closer to be 0 mV, indicating that these 
conjugates were not colloidally stable. Nevertheless, we 
decided to study the photophysical properties and the uptake 
mechanism of these conjugates for comparative reasons with 
our previous 4-5 nm Ru-AuNP conjugates.13a 
   The UV-Visible absorption spectra of bare AuNPs and 1-
3.AuNP are shown in Figure 2, measured in water (Figure 2a), 
and in 10 mM phosphate buffer at pH 7.4, Figure 2b. In both 
solutions, the bare AuNP SPR band was centred at 524 nm, 
demonstrating that it was not dependent on the media. In 
contrast, the surface modification of AuNP by complexes 1-3 
gave rise to a red shift in the absorption spectra of the SPR  
ca.15nm(
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Figure	  2.	  The	  UV-­‐Visible	  absorption	  spectra	  of	  1-­‐3.AuNP	   in:	  (a)	  water	  and	  (b)	  in	  
pH	  7.4	  phosphate	  buffered	  solutions.	  
band (shown as normalized spectra in Figure 2) for all three 
complexes, in both media. In both solvent media the MLCT 
band of the Ru(II) polypyridyl complexes was also visible for 
3.AuNP; the MLCT bands of 1.AuNP and 2.AuNP were 
masked by the SPR band of the AuNP itself. However, the 
higher energy Ru(II) polypyridyl band is clearly visible (See 
ESI, and later discussion). In the case of 3.AuNP the MLCT 
transitions can be seen as broad bands, centred at 417 nm with a 
shoulder at 455 nm, structurally matching that of complex 3 
itself (c.f. the UV-Vis spectra of 1-3 in the ESI). As can be seen 
from Figure 2a, when recorded in water, the SPR band was 
centred for 1-3.AuNP at 535 nm, 547 nm and 525 nm for these  
modified AuNPs, respectively. These solutions were found to 
be stable over a period of several months, as only very minor 
changes were observed in the UV-Vis absorption spectra. The 
stability in solution of 3.AuNP was further monitored by 
recording the UV-Vis absorption spectra over 16 hours. 
   Whilst over the first 6 hours no changes were observed, a 
small reduction (5%) in absorbance was seen between 6-10 
hours for the SPR band. In contrast to that seen in water, in pH 
7.4 phosphate buffered solution, Figure 2b, the absorption 
spectra of 1-3.AuNP were slightly red shifted. Here, both  
1.AuNP and 2.AuNP appeared identical, being centred at 560 
nm, whilst the SPR band for 3.AuNP was centred at 535 nm. 
Such a shift of ca. 15-20 nm is an indication of an 
agglomeration effect in the case of 1.AuNP and 2.AuNP. In the 
case of 3.AuNP, stability measurements were also carried out, 
by observing the changes in the absorption spectra over 16 
hours. Unlike that seen in water, no changes (within 
experimental error) were seen in the SPR band of 3.AuNP over 
this time period, indicating that 3.AuNP was less susceptible to 
aggregation in pH 7.4 buffered solutions. We also carried out 
stability measurements in the presence of 160 mM NaCl, which 
again did not give rise to changes in the absorption spectra of 
3.AuNP over period of 16 hours. 
   The luminescent properties of these surfaced modified AuNPs 
were also investigated. The excitation of 1-3.AuNPs (at the 
λmax for all the MLCT bands as determined for 1-3) gave rise to 
MLCT centered emission at long wavelengths (see discussion 
below) typical of that seen for such complexes. Moreover, the 
excitation spectra of these AuNPs also gave rise to spectra that 
were structurally similar to those observed for the absorption 
spectra of the complexes alone (See ESI). However, as  
 
Figure	   3.	  TEM	   images	   obtained	  using	   functionalized	   nanoparticles:	   (a)	  1.AuNP,	  
(b)	  2.AuNP,	  (c)	  3.AuNP.	  
previously observed, 1-3.AuNP displayed reduced emission in 
comparison to their parent complexes 1-3, despite the fact that 
the complexes are separated from the gold by a covalent 
spacer.15 
   To investigate the structural nature of these surface modified 
AuNPs further, both TEM and DLS analysis were carried out. 
The DLS analysis (See ESI) of these AuNPs in deionized water 
revealed that the hydrodynamic radii of 1.AuNP and 3.AuNP 
were in the expected region of ca. 15 nm, while 2.AuNP gave 
rise to larger structures in solution, being ca. twice of that 
obtained for 1.AuNP and 3.AuNP. However when these 
measurements were repeated in 10 mM phosphate buffer at pH  
7.4 the hydrodynamic radius increased for 1-3.AuNP compared 
to that seen in deionized water (See ESI) indicating some 
degree of agglomeration. Of these, the hydrodynamic radius of 
3.AuNP increased the least, with an ionic radius of ca. 15 nm, 
while both 1.AuNP and 2.AuNP showed the formation of 
much larger structures with hydrodynamic radii of ca. 100 nm 
in solution. These results indicate that 1-3.AuNP are 
susceptible to some degree of aggregation in buffered solution. 
TEM images obtained for 1-3.AuNP in water are shown in 
Figure 3, and clearly show monodisperse spherical 
nanoparticles. The measured average sizes of the core of the 
AuNPs were determined as 15.3 ± 3.0, 15.4 ± 3.3 and 15.8 ± 
3.8 nm for 1.AuNP, 2.AuNP and 3.AuNP respectively.  
   In contrast, the TEM imaging of 1-3.AuNP in 10 mM 
phosphate buffer solutions are shown in Figure 4 and confirm 
the formation of agglomerates of 1.AuNP and 2.AuNP, where 
aggregation of 2.AuNP was particularly apparent. In contrast  
a)## b)##
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Figure	   4.	  TEM	   images	   obtained	  using	   functionalized	   nanoparticles:	   (a)	  1.AuNP,	  
(b)	  2.AuNP,	  (c)	  3.AuNP	  in	  10	  mM	  phosphate	  buffer.	  
3.AuNP did not give rise to any obvious aggregate formation, 
supporting the results observed through DLS analysis. Such 
behavior may be due to the known ability of the TAP ligand 
and related Ru(II) TAP based complexes to participate in 
hydrogen bonding with protic solvents thereby reducing their 
tendency to aggregate. In fact, the hydrogen bonding capability 
of the TAP ligands has been shown to play an important role in 
their interaction with the DNA and this may be an important 
factor when considering their potential in biological 
applications.16 To further investigate these effects we proceeded 
to study the binding behaviour of all three systems with double 
stranded DNA in solution. 
 
Photophysical Analysis of 1.AuNP-3.AuNP with st-DNA  
Having carried out the above photophysical evaluations of 1-
3.AuNP in water and buffered solutions, we conducted 
photophysical studies to establish the interaction of these 
compounds with double stranded DNA. This was achieved 
using UV-vis absorption, fluorescence emission and circular 
dichroism spectroscopy, in 10 mM phosphate buffered solution 
at pH 7.4 in the presence of salmon testes (st) DNA. The 
changes upon binding of complexes 1-3 to DNA has previously 
been investigated in our laboratory and showed that all three 
complexes to have high affinity for st-DNA, with binding 
constants of 5.5-6.5 x 105 M-1 in this phosphate buffer at pH 
7.4.11a All measurements were repeated in triplicate using 
various batches of 1-3.AuNP to ensure reproducibility.  
   The changes observed in the absorbance spectrum of 3.AuNP 
upon titration of these AuNPs with st-DNA, are shown in  
 
Figure	  5.	  (A)	  Representation	  of	  the	  UV-­‐Vis	  titration	  of	  3.AuNP	  with	  st-­‐DNA	  (inset,	  
zoom	  of	  the	  region	  from	  350	  to	  800	  nm);	  (B)	  binding	  isotherms	  of	  the	  MLCT	  band	  
at	  440nm	  and	  the	  SPR	  band	  535	  nm	  and	  (C)	  Bard	  fitting	  plot	  of	  the	  MLCT	  band	  
cantered	  at	  440	  nm.	  
Figure 5a. Each absorption band was clearly affected upon 
addition of aliquots of DNA; 282 nm (due to the transitions of 
the ancillary ligands, π-π*; ε = 50900 M-1 cm-1), MLCT band 
centred at 418 nm (ε = 10700 M-1 cm-1) a shoulder at 462 nm 
and in the SPR band at 535 nm. Abrupt changes were observed 
in the higher energy transitions, as well as in the MLCT band, 
which underwent a 29% hypochromic displacement, with a 
similar (26%) effect being observed for the SPR band centred at 
535 nm within the addition of 0→1 P/D (Phosphate/Dye ratio); 
with further changes occurring up to the addition of 2.5 P/D, as 
demonstrated in Figure 5b. These are similar changes to those 
observed for the complex alone upon titration with st-DNA;11a 
which are consistent with strong association of 3.AuNP with  
DNA. The intrinsic binding constant Kb, was also determined 
using the model of Bard et al. using these changes.17 A 
representative plot of (εa - εf)/(εb - εf) vs. [base pairs] and the 
corresponding best fit of the data to the Bard equation (R = 
0.98) is shown if Figure 5c. From these changes, a binding 
constant Kb of 2.4 x 106 M-1 was determined. This is a 
comparable binding affinity to that seen for other Ru(II) 
complexes, under such experimental conditions.18 The value 
obtained for the binding site for these titrations is unity and an 
indication that 3.AuNP interacts with the DNA by groove 
binding, or electrostatic binding, since this value is much lower 
than the expected value of two commonly seen for interaction 
by intercalation.17 This is not surprising giving that the 
conjugation of these complexes to the AuNPs will have an 
effect on the degree of freedom for the binding of these to the 
biomolecule.  
The high affinity of 3.AuNP and the strong interaction 
observed in the absorption spectra was further confirmed by 
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observing the changes in the fluorescence emission spectra 
upon excitation at 440 nm. The overall changes in MLCT 
emission (centred at 637 nm) are shown in Figure 6, 
demonstrating that the MLCT emission was quenched by ca. 
70%, after the addition of 0.5 P/D of st DNA (as shown as inset 
in Figure 6); being blue-shifted by ca. 15 nm. Once more, 
spectroscopic changes of this nature are in agreement with 
results obtained previously by our group11a and by others for 
similar Ru(II)-polypyridyl complexes containing two TAP 
ligands which have been shown to photo-oxidise guanine 
containing nucleotides through a proton coupled photoinduced 
electron transfer (PCET) process.19 
 
Figure	  6.	  Emission	  spectra	  of	  3.AuNP	  during	  its	  titration	  with	  st-­‐DNA	  (inset,	  the	  
binding	  isotherm	  at	  646	  nm).	  	  
   For comparison with our previously reported Ru-AuNPs, we 
also carried out the titration of 1-2.AuNP with st-DNA. Prior to 
the titration, the absorbance spectrum of 1.AuNP (c.f. ESI, and 
discussion above) possess two bands, one centred at 262 nm (ε 
= 49500 M-1 cm-1) corresponding to the π-π* transitions of the 
ancillary ligands of the Ru(II) which were monitored upon 
titration with DNA as the MLCT band was masked by the SPR 
band of the AuNP. These transitions were blue shifted by ca. 10 
nm compared to the free complex (possibly due to the π-π 
stacking interactions between the aromatic rings of 
neighbouring molecules of 1).20 Upon increasing addition of st-
DNA the π-π* transition initially underwent a hypochromic 
shift up to 1-1.5 P/D followed by a hyperchromic shift 
thereafter. A slight red hypochromic shift was also observed in 
the SPR band upon addition of DNA up to 2 P/D (Figure S9A). 
A very similar effect was observed in the absorption spectrum 
of 2.AuNP upon carrying out such DNA titrations (monitoring 
both the 266 nm ε = 72700 M-1 cm-1 and the MLCT transitions,  
see ESI). Excitation of 1-2.AuNP at 420 nm, corresponding to 
the MLCT band, gave rise to an MLCT emission centred at 600 
nm, which was structurally similar to that of the free complex 
(excitation spectra confirmed this as well). However, upon 
addition of st-DNA, no significant changes were observed in 
the MLCT centred emission spectra. These results confirmed 
that the agglomeration of 1-2.AuNP showed by the TEM 
imaging is hindering these conjugates to interact with the st-
DNA. In our previous study with 4-5nm Ru-AuNP conjugates 
all of them were able to interact with the stDNA whereas in our 
new conjugates it was possible to study in detail the 3.AuNP 
derivative. This could be due to the different stabilization of the 
AuNP. In our previous work the surfactant TOAB was 
employed to prevent aggregation of the AuNP. However, in the 
present work sodium citrate was employed, making that the 
coating of the gold surface implicated the removal of the citrate 
and the consequent aggregation of the Ru-AuNP with the 
exception of 3.AuNP where the availability of the TAP ligands 
to form H-Bonds prevents their aggregation and allows their 
interaction with the stDNA in a similar manner than the 
previous 4-5 Ru-AuNP. 
   To further study the interaction of these modified AuNP 
conjugates with DNA, CD-titrations were also carried out (See 
ESI), by adding various concentrations of 1-3.AuNP to a 
solution of st-DNA and monitoring the changes in the DNA CD 
spectra between 200-300 nm. Significant induced changes were 
observed for the CD-spectra in the presence of 1-3.AuNP. The 
DNA transitions,21 seen as a positive CD-band at 280 nm and a 
negative CD-band at 250 nm were affected, but no long 
wavelength transitions were observed. For 1-3.AuNP, the long 
wavelength DNA-transition was reduced in intensity, while 
lesser changes were seen in the higher energy CD-band. Of 
these, the order of changes were largest in the case of 2.AuNP 
and 3.AuNP, where the 280 nm band was almost fully reduced 
to zero, in the case of 3.AuNP, or with a slight cross over to a 
negative signal in the case of 2.AuNP. While these titrations 
did not induce changes in the MLCT band the loss of the right 
handed helical structure in these CD measurements serve to 
confirm the above results where it is clear that 1-3.AuNPs are 
causing some changes to the double helical structure. 
 
Thermal Denaturation and Cleavage Ability of 1-3.AuNP 
with st-DNA and plasmid DNA, respectively   
Having investigated the interactions of 1-3.AuNP with double 
stranded DNA using various titration experiments, thermal 
denaturation studies were also carried out on st-DNA in the 
presence of 1-3.AuNP ; In the absence of these nano-structures, 
a Tm value of 69.8 ºC was determined for the st-DNA under the 
experimental conditions used. Complexes 1-3 were all shown to 
stabilize double stranded DNA prior to their conjugation to the 
AuNPs (See ESI). The melting profiles of st-DNA upon 
interaction with 1-3.AuNP (See ESI) were measured at P/D = 
10, and all showed only minor changes in the Tm values; these 
being most pronounced with 2.AuNP and 3.AuNP, both of 
which showed a slight increase in the Tm (70.2 ºC). These 
results are similar to that seen for smaller AuNPs previously 
developed in our laboratory11a and indicate that the conjugation 
of Ru(II) complexes to the AuNP surface seems to alter their 
ability to stabilize double stranded DNA. 
   The DNA photocleavage efficiencies of 1-3.AuNP were also 
compared to the known DNA photocleavage agent [Ru(bpy)3]2+ 
by treating pBR322 plasmid DNA (1 mg mL-1) (See Figure and 
Table S1 in ESI) with each of the Ru(II) AuNPs.22 As above, 
the complexes 1-3, all gave rise to nicking of plasmid DNA, 
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determined using horizontal agarose gel electrophoresis. 
However, 3.AuNP showed lower cleavage ability compared to 
the free complex 3, with a 2.1%, 4.6% and 5.4% conversion to 
open form DNA at P/D ratios of 20, 10 and 5, respectively; and 
this small capability was removed in the presence of NaN3. It is 
clear that whilst the above spectroscopic titration results, clearly 
demonstrate high affinity of 3.AuNP for DNA, the thermal 
denaturation measurements do not seem to lead to increased 
stability in double stranded DNA. Moreover, it is clear that 
3.AuNP does cleave DNA to some small extent in the presence 
of light activation, as had been seen for 3. These results clearly 
demonstrate that surface modification of AuNP with 3, has a 
major effect on the ability of the Ru(II) complex to either 
stabilize or cleave DNA; commonly seen properties for Ru(II)-
polypyridine complexes. Hence, the results above suggest that 
these systems would not function as therapeutic candidates, but 
their potential as luminescent biological imaging agents or as 
carriers for other drug substrates (or other type of cargo, such as 
in gene-delivery, c.f. discussion in introduction section) is 
feasible. Therefore the potential as luminescent biological 
imaging agents was investigated further and will be discussed 
below. However, the cause for the lack of these nano-structures 
to carry out functions (i.e. stabiles or cleave DNA) seen for the 
complexes 1-3 alone, seem to stem from their functionalisation 
to AuNP. Above TEM and DLS results strongly suggested 
media dependent agglomeration of 1.AuNP and 2.AuNP with 
the effect being less pronounced for 3.AuNP. In order to 
investigate these results further, we explored the binding of 
these nanostructures to st-DNA using both DLS and TEM 
analysis. 
 
DLS and TEM studies of 1-3.AuNP with DNA 
The DLS studies of 1-3.AuNP with st-DNA were carried out in 
10 mM phosphate buffered solution at different P/D ratios. 
These studies (See Figure 7 and ESI) confirmed the results of 
the spectroscopic studies above, where upon interaction with 
DNA, binding or some sort of self-assembly formation 
occurred which led to significant agglomeration in the case of 
1.AuNP and 2.AuNP, with an increase in the hydrodynamic 
radius of these systems. Given that Ru(II)-polypyridyl 
complexes are well known to either groove bind or intercalate 
with DNA, it is  not unreasonable to expect that such a 
phenomenon might be occurring. In the case of 3.AuNP, these 
particles have a diameter in solution of about 36 nm that 
increased regularly with the addition of st-DNA up to 0.23 P/D. 
Such behaviour clearly demonstrates a gradual self-assembly 
formation between these particles and DNA, where the self-
assembly reached an average diameter of 500 nm. Subsequent 
additions of st-DNA, from 1→100 P/D, did not produce any 
further changes in the measured diameter of these DNA 
aggregated particles. This was further demonstrated by TEM 
analysis as observed in Figure 8 showing the TEM images of 
3.AuNP in the presence of DNA. In the case of conjugates 
1.AuNP and 2.AuNP (Figures S16-S17) there was a similar 
pattern for values of P/D (~0.20), however, at higher values of 
P/D the particle diameter varied randomly, which could  
 
 
Figure	  7.	  Changes	  in	  the	  DLS	  in	  10	  mM	  buffered	  solution	  of	  the	  size	  distribution	  
of	  3.AuNPs	  upon	  increasing	  concentration	  of	  st-­‐DNA	  (expressed	  as	  P/D	  values):	  
(a)	   The	   gradual	   changes	   occurring	   between	  0	   (shown	   in	   red)	   to	   0.23	   P/D	   (fare	  
right	  green	  curve).	  (b)	  The	  changes	  between	  0.23→0.70	  P/D.	  (c)	  zoomed	  in	  onto	  
the	   larger	  DNA	  agglomerated	  3.AuNPs	   changes	   occurring	   from	  1.00→100	  P/D.	  
These	  measurements	  were	  repeated	  three	  times	  using	  freshly	  made	  solutions.	  
indicate a weaker interaction than in the case of 3.AuNP. To 
confirm these results further, TEM studies were carried out 
using samples of 1-3.AuNP treated with different ratios of st-
DNA (P/D of 0, 0.23, 1.00 and 8.00, respectively) in 10 mM 
phosphate buffer solutions. The results for 3.AuNP are shown 
in Figure 8 (See ESI for 1.AuNP and 2.AuNP). Comparing 
Figure 8a with that of Figure 8b, it is clear that initially the 
nanoparticles are more monodisperse while at a P/D-ratio =  
  
Figure	   8.	   Images	   obtained	   of	   3.AuNP	   by	   TEM	   at	   different	   P/D	   ratios:	   (a)	   in	  
absence	  of	  any	  DNA;	  (b)	  P/D	  =	  0.23,	  (c)	  P/D	  =	  1.00,	  (d)	  P/D	  =	  8.00.	  

















Journal	  Name	   ARTICLE	  
This	  journal	  is	  ©	  The	  Royal	  Society	  of	  Chemistry	  2012	   J.	  Name.,	  2012,	  00,	  1-­‐3	  |	  7 	  
0.23, clusters are beginning to form due to interaction with the 
st-DNA. Upon further increasing the P/D ratio, the self-
assembly formation between 3.AuNP and st-DNA, is even 
more apparent as seen in Figures 8c and 8d, respectively.  
   In the case of 1.AuNP continuous increments of the size of 
the AuNPs aggregates were observed with the addition of the 
increasing concentrations of st-DNA (c.f. ESI). While in the 
case of 2.AuNP fast agglomeration of these nanoparticles (c.f. 
ESI) occurred instantly upon addition of st-DNA. These TEM 
results confirm a strong self-assembly interaction with st-DNA 
where 3.AuNP seems to form the most ordered assemblies. In 
order to probe the effect that this self-assembly process may 
have in biological systems we next set about investigating both 
the cytotoxic and cellular uptake abilities of 1-3.AuNP. 
 
Cytotoxic studies of 1-3.AuNP in vitro   
To assess the cytotoxic effects of 1-3.AuNP, studies were 
carried out in vitro using the cervical cancer cell line HeLa, and 
Alamar blue cell viability assay. The cytotoxicity was 
investigated both with and without light irradiation; the latter 
being carried out in order to establish, if these systems were 
phototoxic, particularly in the case of 3.AuNP, which is known 
to form adducts with DNA upon irradiation. The HeLa cells 
were initially treated in the dark and either remained incubated 
in the dark or exposed to mild irradiation of 4 J/m² of light.). 
Hela cells treated with 3.AuNP and incubated in the dark did 
not show a reduction in cell viability when compared to the 
untreated control cells, indicating that these AuNPs were not 
cytotoxic in the dark. Upon light irradiation there was a small 
reduction in HeLa cell viability when compared to the untreated 
control cells (Figure 9). Similar results were observed for 
1.AuNP (See ESI). However in the case of 2.AuNP, a slight 
reduction in cell viability was observed both in the dark and 
upon light activation (See ESI). 
 
Fluorescence Confocal Microscopy Studies in HeLa Cells 
Fluorescence confocal microscopy was used for real time 
observation of the complexes within live HeLa cells, the results 
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of which are shown in Figure 10. The HeLa cells were 
incubated with the compounds in the dark for various time 
points and then imaged using fluorescence confocal 
microscopy. The bright field images (BF), Figure 10, show the 
morphologies of the treated cells remained similar to the 
untreated control cells (Figure S21-S22). From the BF images 
3.AuNP can be seen as dense aggregates within the cytoplasm 
of the cells, which increase or become more dense/darker 
overtime. 
   The nucleus of the cells was stained with the nuclear stain 
DAPI that emits blue fluorescence upon excitation with the 
405 nm laser. By exciting the AuNP at the MLCT absorption 
using a 488 nm laser and measuring the MLCT based emission 
between 600-700 nm they produce red fluorescence within the 
live Hela cells (FL channel). In Figure 10 this red fluorescence 
can be seen to overlap directly with the dense patches observed 
in the bright field images, confirming the successful uptake of 
3.AuNP into these cells. Despite 1-3.AuNP not being as 
luminescent as the free complexes 1-3, their emission can be 
clearly seen within the cells. Almost all cells in the field of 
view contained either the dense patches in the bright field 
images or red fluorescence due to 3.AuNP. Moreover, it can be 
seen that 3.AuNP was not distributed throughout the cell 
uniformly, but rather appeared as spots, which over time 
became brighter and moved closer to the nucleus. By varying  
the incubation times we concluded that the uptake of the AuNP 
complexes increased over time and was therefore time-
dependent, Figure 10. We also noted that over time the 
compound moved closer towards the nucleus but there was no 
evidence of the compounds entering the nucleus of the cells. 
These results are representative for all compounds (the same 
results were observed for both 1.AuNP and 2.AuNP, Figure 
S19-S20). We next imaged the HeLa cells that had been treated 
with 3.AuNP for 24 h, Figure 11. From these images it was 
clear that 3.AuNP was not uniformly distributed throughout the 
cell but accumulated at one side of the nucleus as seen in the 
images as black spots or red fluorescence after a period. The 
emission arising from 3.AuNP was notably brighter than at the 
earlier time points as demonstrated in Figure 10, an observation 
that may suggest either increased fluorescence due to 
aggregation or an increase in the concentration of 3.AuNP 
within the cell over time. These images also confirmed that the 
3.AuNP was not localizing within the nucleus, but instead the 
results suggest that it may be in vesicle like structures due to 
the spherical shape of both the ‘emission spots’ and the dense 
patches observed in Figure 11b. Hence, these results clearly 
demonstrate that 3.AuNP is rapidly taken up by cells and that, 
whilst the precise localization of the NPs is not clear, 
accumulation close to the nuclear membrane is observed in 
HeLa cells by using TEM imaging.  
 
TEM Time Dependent Uptake and Localisation Studies 
The time dependent uptake of 3.AuNP by HeLa cells was also 
measured using TEM, Figure 12. The results clearly 
demonstrate that the AuNPs are taken up by HeLa cells over 
time. Due to the AuNPs favorable size of 15 nm 3.AuNP, 
 
Figure	  11.	   Fluorescence	   confocal	  microscopy	   images	  of	  HeLa	   cells	   treated	  with	  
20µM	  3.AuNP	  for	  24hr.	  	  Fluorescence	  image	  (AàC)	  where	  nuclear	  stain	  DAPI	  (B)	  
is	  blue	  and	  3.AuNP	  in	  red	  and	  brightfield	  images	  (C).	  
 
uptake could be easily imaged and observed as dark spots 
within the HeLa cells, even after short incubation times. 
Moreover, Figure 12b, c, e and f, all demonstrated the presence 
of 3.AuNP within the HeLa cells in what appear to be 
endocytic vesicles. The imaging also shows that cells treated 
with 3.AuNP have the same morphology as that observed for 
the untreated HeLa cells, Figure 12A, confirming that the 
AuNPs did not exhibit any toxicity towards the cells at that 
concentration (20 µM) or exposure time (1-24 hours). These 
results also confirm our previous observations that 3.AuNP is 
not toxic towards HeLa cells in the dark. The high 
magnification of the TEM images and the larger diameter of 
3.AuNP allowed individual particles to be observed and 
measured within vesicles, confirming that the AuNPs maintain 
their original morphology once inside the cells (Figures S23-
S25). These results also demonstrate the ease with which such 
Ru(II) polypyridyl modified AuNPs can be internalized by cells 
and suggest that 1-3.AuNP show significant potential for 
application in cellular biology as either cargo delivery agents or 
as diagnostic fluorescence imaging probes. Such factors are 
further emphasized by the potential to easily functionalize the 
surfaces of such AuNPs by other Transition metal 
complexes/ligands, etc. The TEM time dependent imaging 
demonstrated that 3.AuNP was taken up by the cells within 1-2 
hours, and localized within what appear to be single membrane 
vesicles located in the cytoplasm of the cell. Moreover, after 4-
6 hours, 3.AuNP was seen to be located at the nuclear edge 
(Figure 11) as seen previously in the confocal results in Figure 
10. After 24 hours incubation, 3.AuNP remained in vesicles 
within the HeLa cell explaining why the AuNPs appeared as 
spherical aggregates in the brightfield images of our previous 
confocal images, Figures 10 and 11. There was no evidence 
from the TEM images of 3.AuNP free in the cytoplasm or in 
the nucleus of the HeLa cells. These results would confirm that 
as anticipated the uptake and delivery of 3.AuNP is by an 
endocytotic mechanism. 
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Figure	  12.	  TEM	  images	  of	  HeLa	  cells	  incubated	  with	  3.AuNP	  (20µM)	  for	  (B)	  1h	  (C)	  
2h	  (D)	  4h	  (E)	  6h	  (F)	  24h	  or	  left	  untreated	  (A).	  
We also investigated the uptake and localization of 3.AuNP in 
the Murine macrophage cell line; RAW 264.7, using TEM, 
Figure 13. After 24 h incubation 3.AuNP was located both 
inside the RAW cells within vesicle like structures (Fig.13 A-
B) and at the outer edge of the cells plasma membrane (Fig.13 
C-D). Similar to our studies in HeLa cells individual particles 
could be visualized within the vesicle but not free in the 
cytoplasm or in the nuclei of the cells. These results confirm the 
possibility of endocytosis as the uptake mechanism involved 
with these large AuNPs. The RAW cells displayed intact 
membranes and similar morphology to untreated RAW cells 
(See ESI) further emphasizing 3.AuNPs lack of dark 
cytotoxicity. 
Conclusion	  
In this present work we have synthesized three Ru(II) 
polypyridyl functionalized AuNPs 1-3.AuNP with an average 
size of ca. 15 nm, and a hydrodynamic radius of ca. 30 nm. We 
have demonstrated that these structures are stable in aqueous 
buffered solution, and that all give rise to absorption spectra 
consisting of the MLCT absorption contribution from the Ru(II) 
polypyridyl complexes and from the gold SPR bands. 
Moreover, upon excitation of the MLCT absorption a red 
MLCT centered emission is observed, despite quenching by the 
gold surface. We further show, using both TEM and DLS 
techniques that of the three systems 3.AuNP is the most highly 
stable remaining unchanged in solution over a period of 16 
hours, even in the presence of buffer, high ionic strength or in 
the presence of DNA. In the case of 1.AuNP and 2.AuNP 
larger aggregates are formed over time, a phenomenon that 
becomes more apparent in the presence of DNA. We further 
demonstrate that these AuNPs are rapidly taken up into live 
human cancer cells in vitro; the mechanism of which appears to 
be endocytosis as demonstrated by both TEM and confocal 
fluorescence microscopic imaging. Upon excitation of the 
MLCT transition, these AuNPs display red emission within 
cells with no observed cytotoxicity. We show that these AuNPs 
are localized within the cytosol, and over time (24 hours) 
migrate towards the nuclear membrane. Using TEM imaging, 
we further show that these AuNPs are taken into cells and 
accumulate within vesicles. Cytotoxic analysis using cell 
viability assays confirmed that 1-3.AuNP are relatively non-
toxic either in the dark or upon light excitation. Overall, the 
results from this investigation clearly demonstrate, the potential 
use of 15 nm Ru(II) functionalized AuNPs as valuable tools for 
chemical biology. The results obtained from our investigation 
shed further light on the behavior of 1-3.AuNP in a biological 
setting and overwhelmingly support their possible use in 
cellular applications. We are currently pursuing these and 
related areas and results will be published in due course. 
 
Experimental	  
Synthesis of the AuNPs and functionalization with the Ru(II)-
polypyridyl complexes: For the preparation of the AuNP we 
chose the method of reducing gold with sodium citrate, which 
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resulted in the formation of 15-20 nm AuNP.23 A solution of 
HAuCl4 (0.040 g) in Millipore water (300 mL) was boiled at 
100 ºC for 15 minutes. To this solution 10 mL of 4.04 x 10-2 M 
sodium citrate solution was added and the solution was left to 
reflux for another 15 minutes. During this time the solution 
changed its color from yellow to dark purple to finally turn into 
a wine color solution, and it was left to cool down to room 
temperature before using. For the functionalization of the 
AuNPs with the Ru(II)-polypyridyl complexes a solution was 
prepared by adding 1 mL of a 0.7 x 10-3 M solution of the 
corresponding Ru(II) polypyridyl complex to 1 mL of the 
AuNPs solution (3.38 x 10-4 M) in water. The mixture was left 
stirring overnight at pH 3 to improve the loading of the 
complexes onto the surface of the AuNPs adapting the method 
of J. Liu et al. in literature.24 The addition of a concentrated 
aqueous solution of NH4PF6 (0.5 mL) afforded flocculation of a 
dark solid which was collected by centrifugation and washed 
with H2O (3 x 10 mL). The solid was redissolved in MeCN 
(10 mL) before addition of a conc. solution of TBACl resulted 
in the formation of a flocculate which was collected by 
centrifugation and washed with MeCN (3 x 10 mL) before 
being dried under high vacuum. 
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